We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Italian officials and drug manufacturers are currently discussing pharmaceutical pricing. The country's health minister has warned that drugmakers will have to "justify" their prices, rather than merely informing the government.
Anadys Pharmaceuticals, Inc. today announced that it has filed a preliminary prospectus supplement to its shelf registration statement with the Securities and Exchange Commission relating to a proposed underwritten public offering of 4,000,000 shares of its common stock.
Human Genome Sciences, Inc. announced today that it has received $7 million in payments from its collaborator, GlaxoSmithKline (GSK), related to the achievement of manufacturing and preclinical development milestones for GSK716155 (formerly known as Albugon), a drug currently in late-stage preclinical development for potential use in the treatment of diabetes.
Samaritan Pharmaceuticals Inc., a developer of innovative drugs, announced today its plans to expand its business to Athens, Greece, (Samaritan Europe), creating a European presence.
Early Monday, Teva Pharmaceuticals Industries Ltd., a developer and marketer of generic and human drugs, announced higher second quarter earnings as revenues increased.
Sun Pharmaceutical Industries Ltd reported 67.55 per cent rise in net profit on Friday at Rs 125.77 crore for the quarter ended June 30, 2005 as compared to Rs 75.06 crore for the corresponding quarter in previous fiscal year.
Kenya is to launch a free treatment scheme for HIV/AIDS sufferers,
according to government officials. The programme -- to be financed by the UN-administered Global Fund -- will be available for those unable to pay the current KES100 (US$1.31) fee for ARV drugs.